Jeffrey regularly advises major pharmaceutical companies in connection with licensing and collaboration agreements; represents semiconductor and other technology companies in connection with development and licensing agreements; leads the technology and intellectual property aspects of major corporate transactions; and advises on the treatment of intellectual property matters in bankruptcy cases.
Jeffrey lived in Japan from May 1997 to May 1998 where he worked in-house on loan to the headquarters of Panasonic Corporation.
Jeffrey is ranked Band 1 for Technology in New York by Chambers USA, where clients note “he’s just extremely thorough and he has the memory of an elephant” and “he’s one of the top lawyers in this space, a very knowledgeable and impressive individual.” He is also recommended for Patents: Licensing, Technology Transactions, Media and Entertainment: Transactional and Healthcare: Life Sciences by Legal 500 US. Jeffrey is recognized as an “IP Star” for IP Transactions and Trademarks by Managing Intellectual Property and a “Life Sciences Star” by LMG Life Sciences Guide and was named 2022 and 2020 “Lawyer of the Year” for Technology Law in New York by Best Lawyers in America. Jeffrey was shortlisted as “Practitioner of the Year (IP Transactions)” for Managing Intellectual Property’s 2022 Americas Awards. He is recognized as a “Global Leader” in New York by IAM Global Leaders and is “Highly Recommended” by IAM Patent 1000, where clients have noted he has “a stellar ability to see the forest through the trees, is a clear and concise draftsman and a constructive negotiator,” and he is “the kind of sophisticated IP lawyer you need on a tough deal – he understands his clients’ industry and business, and fights hard while communicating clearly in negotiations to get to a resolution.” Jeffrey was also named a 2016 Technology “MVP” by Law360.